Endovascular Perforation Model for Subarachnoid Hemorrhage Combined with Magnetic Resonance Imaging (MRI)
December 16th, 2021
4.1K views
Here we present a standardized SAH mouse model, induced by endovascular filament perforation, combined with magnetic resonance imaging (MRI) 24 h after operation to ensure the correct bleeding site and exclude other relevant intracranial pathologies.
Overview
This study presents a standardized mouse model of subarachnoid hemorrhage (SAH) induced by endovascular filament perforation, combined with MRI to assess the bleeding site and exclude other intracranial pathologies. The approach facilitates the quantification of bleeding volumes for further analyses.
Key Study Components
Area of Science
- Neuroscience
- Neuroimaging
- Experimental Models
Background
- Subarachnoid hemorrhage presents significant clinical challenges.
- Modeling SAH in mice allows for detailed investigation of bleeding pathology.
- Magnetic resonance imaging (MRI) provides insights into bleeding sites and volumes.
- Understanding the mechanics of SAH can aid in developing therapeutic strategies.
Purpose of Study
- To develop a method for inducing SAH in mice.
- To integrate MRI for verifying bleeding locations.
- To quantify bleeding volumes for subgroup analysis.
Methods Used
- The study utilized a surgical model involving endovascular filament perforation.
- Mice underwent surgery to induce SAH, followed by postoperative MRI imaging at 24 hours.
- Imaging was analyzed using T2 weighted MRI scans to assess bleeding severity.
- Careful dissection and suturing techniques were used to manage the surgical procedure.
- Data were processed for SAH grading and volumetric assessment.
Main Results
- A significant portion of mice exhibited various grades of SAH as determined through MRI imaging.
- Results showed that 14% of mice displayed no radiological evidence of SAH.
- The majority of mice demonstrated SAH grades between one and three, indicating varying severity.
- Quantification of bleeding volume revealed significant differences among subgroups.
Conclusions
- This study successfully demonstrates a standardized SAH model for research purposes.
- Integration of MRI allows for enhanced verification of injury and bleeding severity.
- The findings support future studies on SAH pathophysiology and potential therapeutic approaches.
Frequently Asked Questions
What are the advantages of the endovascular perforation model?
This model enables precise induction of SAH while allowing for real-time verification of bleeding locations through MRI, which is crucial for experimental accuracy.
How is surgery performed to induce SAH in mice?
Surgery involves extensive dissection to access the carotid artery, inserting a filament to induce bleeding, and then monitoring the procedure for any complications.
What types of data are obtained from the MRI scans?
MRI scans provide detailed assessments of bleeding locations, severities, and volumes, which are critical for evaluating the extent of SAH.
How can this method contribute to SAH research?
By providing a reliable model for induced SAH, this approach facilitates investigations into the pathological mechanisms and potential treatments for the condition.
What are the key limitations of this model?
Limitations may include the replication of human SAH complexities and the need for careful surgical techniques to avoid complications.
Can this model be adapted for other types of intracranial pathologies?
While primarily designed for SAH, adaptations may enable investigations into other vascular-related pathologies through modifications in the surgical approach.
Executive Industry Relevance
Standardized endovascular perforation models combined with MRI enable precise quantification and grading of subarachnoid hemorrhage (SAH) in preclinical research. This approach enhances predictive confidence in early-stage neurovascular target validation and supports robust experimental subgrouping based on objective imaging data. Integrating imaging-based verification reduces mechanistic ambiguity and strengthens translational continuity for neurovascular drug discovery portfolios.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables rigorous interrogation of neurovascular injury mechanisms in disease-relevant systems.
- Supports functional target validation by correlating intervention with quantifiable SAH outcomes.
- Facilitates mechanistic de-risking through exclusion of off-target intracranial pathologies via MRI.
- Improves predictive confidence for advancing neurovascular targets in the pipeline.
Screening & Assay Development
- Provides a validated in vivo model for reproducible induction and grading of SAH.
- Delivers quantitative MRI-based outputs for standardized assay readouts.
- Enables reliable stratification of experimental cohorts for compound evaluation.
- Supports downstream screening workflows with robust biological endpoints.
Translational & Preclinical Research
- Aligns preclinical models with clinical imaging modalities for translational biomarker development.
- Ensures continuity from discovery through preclinical validation by integrating imaging-based endpoints.
- Reduces risk of confounding variables by excluding non-SAH pathologies post-surgery.
- Supports risk-adjusted advancement decisions based on objective volumetric data.
Pipeline & Workflow Integration
This model positions within the early discovery to preclinical continuum, enabling hypothesis testing, target validation, and translational biomarker alignment for neurovascular indications.
- Discovery Biology: Supports hypothesis-driven interrogation of SAH mechanisms and target effects.
- Screening: Provides reproducible, quantitative MRI outputs for assay standardization.
- Analytics: Enables volumetric grading and subgroup analysis for robust data comparison.
- Translational Research: Bridges preclinical and clinical imaging endpoints for biomarker continuity.
- Enterprise Reuse: Establishes a reusable platform for neurovascular injury modeling and intervention testing.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in neurovascular research.
- Operational Value: Standardizes model induction and imaging-based grading for reproducibility.
- Strategic Value: Enables informed go/no-go decisions and capital-efficient portfolio triage.
- Portfolio Impact: Supports risk-adjusted prioritization and advancement of neurovascular assets.
Implementation Considerations
- Requires expertise in microsurgical techniques and small animal anesthesia.
- Demands access to high-field MRI instrumentation and imaging analysis software.
- Necessitates cross-team standardization of surgical and imaging protocols.
- Adaptation across mouse strains or other species may require protocol optimization.
- Potential limitations include surgical complexity and model-specific mortality rates.
Biopharma FAQs
Why does null hypothesis testing matter for MRI-based SAH grading?
Null hypothesis testing enables objective assessment of intervention effects on SAH volume and grade, ensuring that observed differences are statistically robust and not due to random variation in the model.
How does independent variable isolation fit the endovascular perforation workflow?
Isolating variables such as surgical technique or compound administration allows teams to attribute changes in MRI-quantified bleeding directly to the intervention, supporting mechanistic clarity in discovery-stage studies.
What do quantitative dependent variable measurements enable in this model?
Quantitative MRI measurements of bleeding volume and grade enable precise subgrouping, facilitate dose-response analyses, and support reproducible comparisons across experimental arms.
Why are replication requirements critical for cross-functional SAH studies?
Replication ensures that MRI-based SAH grading and volumetric outputs are consistent across operators and sites, supporting cross-functional data integration and collaborative decision-making.
What statistical analysis capabilities are required before implementing MRI-based SAH quantification?
Teams must be equipped to perform volumetric data analysis, group comparisons, and significance testing to validate experimental findings and support portfolio advancement decisions.
